FROM TRIAZINES AND TRIAZENES TO TEMOZOLOMIDE

被引：52

作者：

STEVENS, MFG ^{[1
]}

NEWLANDS, ES ^{[1
]}

机构：

[1] CHARING CROSS HOSP,DEPT MED ONCOL,CRC PHASE I II CLIN TRIALS CTR,CRC LABS,LONDON W6 8RF,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 07期

关键词：

D O I：

10.1016/S0959-8049(05)80221-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1045 / 1047

页数：3

共 21 条

[1] STUDIES ON MECHANISM OF ACTION OF TUMOR INHIBITORY TRIAZENES [J].

AUDETTE, RCS ;

CONNORS, TA ;

MANDEL, HG ;

MERAI, K ;

ROSS, WCJ .

BIOCHEMICAL PHARMACOLOGY, 1973, 22 (15) :1855-1864

[2] PYRAZOLOTRIAZINES - A NEW CLASS OF TUMOUR-INHIBITORY AGENTS [J].

BALDWIN, RW ;

PARTRIDG.MW ;

STEVENS, MFG .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1966, S 18 :S1-&

[3] EGF RECEPTOR AMPLIFICATION AND EXPRESSION IN HUMAN BRAIN-TUMORS [J].

CHAFFANET, M ;

CHAUVIN, C ;

LAINE, M ;

BERGER, F ;

CHEDIN, M ;

ROST, N ;

NISSOU, MF ;

BENABID, AL .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) :11-17

[4]

CITRON M, 1991, CANCER RES, V51, P4131

[5]

CLARKE DA, 1955, P SOC EXP BIOL MED, V90, P484

[6]

EGE G, 1979, TETRAHEDRON LETT, P4253

[7]

GIBSON NW, 1986, CANCER RES, V46, P4995

[8] ANTI-TUMOR 1-(X-ARYL)-3,3-DIALKYLTRIAZENES .2. ROLE OF CORRELATION ANALYSIS IN DECISION-MAKING IN DRUG MODIFICATION - TOXICITY QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF 1-(X-PHENYL)-3,3-DIALKYLTRIAZENES IN MICE [J].

HANSCH, C ;

HATHEWAY, GJ ;

QUINN, FR ;

GREENBERG, N .

JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (06) :574-577

[9]

HICKMAN JA, 1985, CANCER RES, V45, P3008

[10]

HORSPOOL KR, 1990, J MED CHEM, V30, P1393

← 1 2 3 →